
Ethizone S 500mg/250mg Injection
Marketer
Human Biolife India Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Ethizone S 500mg/250mg Injection
Combiflox, a 500mg/250mg injectable antibiotic, combats bacterial infections by hindering microbial proliferation. Administered solely under medical guidance, this medication necessitates adherence to the prescribed dosage schedule. Complete the full course of treatment, regardless of symptom improvement, to prevent treatment failure. Abrupt cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms require immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, dyspnea). Inform your physician about all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, nutritious food, and sufficient hydration promote faster recovery. Your doctor may order lab tests to monitor the medication's effects.
Primary Ingredients of Ethizone S 500mg/250mg Injection
No text was provided. Please provide the text you want me to rephrase.
Uses of Ethizone S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Ethizone S 500mg/250mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.
Common Side effects of Ethizone S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ethizone S 500mg/250mg Injection:
Administering this medication will be done by your physician or their nursing staff; self-medication is strictly prohibited.
How Ethizone S 500mg/250mg Injection works:
Ethizone S Injection, containing 500mg Ceftriaxone and 250mg Sulbactam, combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, by countering bacterial resistance enzymes, strengthens Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Ethizone S 500mg/250mg Injection use alongside alcohol consumption presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Ethizone S 500mg/250mg Injection is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, corresponding data from human trials are scarce.
Breast feedingCAUTION
The administration of Ethizone S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ethizone S 500mg/250mg Injection can induce drowsiness, blurred vision, dizziness, and reduced awareness. Operation of vehicles is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ethizone S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Caution is advised when administering Ethizone S 500mg/250mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is recommended. Dosage alteration for Ethizone S 500mg/250mg Injection is not suggested for those with mild or moderate liver dysfunction.
What if you forget to take Ethizone S 500mg/250mg Injection :
Omitting a scheduled dose of Ethizone S 500mg/250mg Injection necessitates contacting your physician.
Facts to Know About Ethizone S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
